Moderna has reported preliminary clinical ... "We believe that a bivalent booster vaccine, if authorised, would create a new tool as we continue to respond to emerging variants," added Bancel.

Five years ago, on March 11, the World Health Organization declared COVID-19 a global pandemic. The vaccines “underwent the most intensive safety analysis in U.S. history." ...

Dr. Marty Makary, President Donald Trump's choice to lead the Food and Drug Administration, pointed out the Biden ...

The Yale School of Medicine's Dr. Scott Roberts recommends that adults who were vaccinated before 1968 should consider ...

The UK has become the first country in the world to authorise an updated COVID-19 booster vaccine directed at the Omicron variant, giving a green light to Moderna's mRNA-1273.214 shot.

Moderna developed its vaccine in partnership with the National ... making this approach potentially less useful if booster shots need to be given. Viral-vectored vaccines, developed by ...

The Iowa Senate bill alters a proposal that would have penalized administering gene-based vaccines including the COVID-19 ...

The Patent Trial and Appeal Board agreed with Pfizer and its German partner that Moderna's patents were invalid based on "prior art" that disclosed the inventions before Moderna patented them. The ...

“Many didn’t get a COVID booster,” he said ... community in Massachusetts. Moderna, a Cambridge biotech, fielded one of the two messenger RNA vaccines and now has a crop of new vaccines ...

“The companies told the PTAB in the petitions that Moderna’s patents include ‘unimaginably broad claims directed to a basic idea.’” Patent Trial and Appeal Board (PTAB) docket entries ...